|
|
regulation of exocytosis
|
GO:0017157 |
46 |
0.898
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.849
|
|
|
|
dicarboxylic acid biosynthetic process
|
GO:0043650 |
4 |
0.824
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.780
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.763
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.735
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.728
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.723
|
|
|
|
vesicle organization
|
GO:0016050 |
62 |
0.677
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.650
|
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.593
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
56 |
0.586
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.569
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.517
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.513
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.486
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.477
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.476
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.463
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
125 |
0.442
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
142 |
0.420
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.414
|
|
|
|
endosomal transport
|
GO:0016197 |
129 |
0.405
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
132 |
0.395
|
|
|
|
negative regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043154 |
46 |
0.385
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.377
|
|
|
|
cellular response to endogenous stimulus
|
GO:0071495 |
336 |
0.370
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.369
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.368
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.351
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
97 |
0.340
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
144 |
0.332
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.329
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
97 |
0.328
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.327
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
106 |
0.310
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.310
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.309
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
111 |
0.309
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.302
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.296
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.257
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
227 |
0.254
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
84 |
0.248
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
69 |
0.244
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
42 |
0.238
|
|
|
|
associative learning
|
GO:0008306 |
1 |
0.231
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.230
|
|
|
|
negative regulation of cysteine type endopeptidase activity
|
GO:2000117 |
48 |
0.224
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.216
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.205
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
108 |
0.194
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
157 |
0.194
|
|
|
|
gtp catabolic process
|
GO:0006184 |
237 |
0.189
|
|
|
|
cytokinesis
|
GO:0000910 |
96 |
0.188
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.184
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.181
|
|
|
|
autophagy
|
GO:0006914 |
88 |
0.180
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.178
|
|
|
|
regulation of protein acetylation
|
GO:1901983 |
25 |
0.177
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.174
|
|
|
|
organelle assembly
|
GO:0070925 |
176 |
0.171
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.164
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.161
|
|
|
|
startle response
|
GO:0001964 |
3 |
0.156
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.155
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.155
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
116 |
0.154
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.152
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
191 |
0.151
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.150
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.149
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.148
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
59 |
0.144
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.143
|
|
|
|
amino acid import
|
GO:0043090 |
4 |
0.138
|
|
|
|
response to steroid hormone
|
GO:0048545 |
80 |
0.135
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.134
|
|
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.130
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.128
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
185 |
0.127
|
|
|
|
system process
|
GO:0003008 |
349 |
0.120
|
|
|
|
regulation of gtpase activity
|
GO:0043087 |
180 |
0.120
|
|
|
|
gastrulation
|
GO:0007369 |
51 |
0.117
|
|
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.116
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.112
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.111
|
|
|
|
positive regulation of vesicle fusion
|
GO:0031340 |
4 |
0.109
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.107
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
42 |
0.104
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.100
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
172 |
0.098
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.098
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
209 |
0.096
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.095
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
89 |
0.094
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.093
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.092
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
117 |
0.092
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
79 |
0.089
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.088
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
76 |
0.087
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
91 |
0.086
|
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
158 |
0.083
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
232 |
0.083
|
|
|
|
polyamine metabolic process
|
GO:0006595 |
4 |
0.083
|
|
|
|
cell aging
|
GO:0007569 |
52 |
0.082
|
|
|
|
rna processing
|
GO:0006396 |
255 |
0.082
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.081
|
|
|
|
negative regulation of chromosome organization
|
GO:2001251 |
48 |
0.081
|
|
|
|
regulation of extracellular vesicular exosome assembly
|
GO:1903551 |
4 |
0.081
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.079
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.079
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
51 |
0.076
|
|
|
|
regulation of histone acetylation
|
GO:0035065 |
19 |
0.076
|
|
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.075
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.074
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.072
|
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.071
|
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
186 |
0.069
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
78 |
0.065
|
|
|
|
response to light stimulus
|
GO:0009416 |
87 |
0.064
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
85 |
0.064
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
85 |
0.064
|
|
|
|
negative regulation of growth
|
GO:0045926 |
97 |
0.063
|
|
|
|
embryonic morphogenesis
|
GO:0048598 |
85 |
0.063
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.063
|
|
|
|
protein homooligomerization
|
GO:0051260 |
100 |
0.063
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.062
|
|
|
|
positive regulation of organelle assembly
|
GO:1902117 |
17 |
0.062
|
|
|
|
positive regulation of myeloid cell apoptotic process
|
GO:0033034 |
2 |
0.061
|
|
|
|
cellular response to lipid
|
GO:0071396 |
127 |
0.060
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.060
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.060
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.060
|
|
|
|
protein acylation
|
GO:0043543 |
138 |
0.060
|
|
|
|
cellular response to starvation
|
GO:0009267 |
58 |
0.059
|
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
37 |
0.058
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.058
|
|
|
|
response to interferon gamma
|
GO:0034341 |
39 |
0.058
|
|
|
|
wound healing
|
GO:0042060 |
115 |
0.057
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
60 |
0.056
|
|
|
|
activation of protein kinase activity
|
GO:0032147 |
90 |
0.056
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.056
|
|
|
|
growth
|
GO:0040007 |
202 |
0.053
|
|
|
|
response to nutrient
|
GO:0007584 |
20 |
0.052
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
182 |
0.051
|
|
|
|
hormone secretion
|
GO:0046879 |
65 |
0.051
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.050
|
|
|
|
positive regulation of peptidyl serine phosphorylation
|
GO:0033138 |
42 |
0.049
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.049
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
72 |
0.049
|
|
|
|
response to nutrient levels
|
GO:0031667 |
81 |
0.048
|
|
|
|
nuclear transport
|
GO:0051169 |
179 |
0.048
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.048
|
|
|
|
embryonic organ development
|
GO:0048568 |
36 |
0.047
|
|
|
|
atp metabolic process
|
GO:0046034 |
176 |
0.047
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.047
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.046
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
185 |
0.045
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
101 |
0.045
|
|
|
|
ossification
|
GO:0001503 |
121 |
0.044
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.044
|
|
|
|
mrna metabolic process
|
GO:0016071 |
175 |
0.044
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
207 |
0.043
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
63 |
0.042
|
|
|
|
response to alcohol
|
GO:0097305 |
64 |
0.042
|
|
|
|
l amino acid import
|
GO:0043092 |
4 |
0.042
|
|
|
|
spermidine metabolic process
|
GO:0008216 |
3 |
0.041
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
48 |
0.040
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.039
|
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
187 |
0.039
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.039
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.038
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.037
|
|
|
|
exocytosis
|
GO:0006887 |
71 |
0.037
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.037
|
|
|
|
negative regulation of cellular component movement
|
GO:0051271 |
106 |
0.037
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.037
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.034
|
|
|
|
stress activated mapk cascade
|
GO:0051403 |
93 |
0.034
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
239 |
0.033
|
|
|
|
axon cargo transport
|
GO:0008088 |
2 |
0.033
|
|
|
|
spermatid development
|
GO:0007286 |
4 |
0.033
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
103 |
0.032
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
88 |
0.032
|
|
|
|
response to starvation
|
GO:0042594 |
59 |
0.032
|
|
|
|
positive regulation of leukocyte activation
|
GO:0002696 |
80 |
0.032
|
|
|
|
cellular hormone metabolic process
|
GO:0034754 |
41 |
0.032
|
|
|
|
purine ribonucleoside monophosphate catabolic process
|
GO:0009169 |
158 |
0.031
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.031
|
|
|
|
regulation of exosomal secretion
|
GO:1903541 |
12 |
0.031
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.031
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.031
|
|
|
|
telomere organization
|
GO:0032200 |
33 |
0.031
|
|
|
|
response to growth factor
|
GO:0070848 |
205 |
0.031
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
166 |
0.031
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.030
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
2 |
0.029
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.029
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
83 |
0.029
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
139 |
0.029
|
|
|
|
oocyte development
|
GO:0048599 |
1 |
0.028
|
|
|
|
positive regulation of exocytosis
|
GO:0045921 |
35 |
0.028
|
|
|
|
digestive system development
|
GO:0055123 |
75 |
0.028
|
|
|
|
regulation of organelle assembly
|
GO:1902115 |
40 |
0.027
|
|
|
|
translation
|
GO:0006412 |
132 |
0.027
|
|
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.027
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
24 |
0.027
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
126 |
0.027
|
|
|
|
axonogenesis
|
GO:0007409 |
31 |
0.027
|
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.027
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
0.027
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
183 |
0.027
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.027
|
|
|
|
oocyte differentiation
|
GO:0009994 |
2 |
0.026
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.026
|
|
|
|
hindlimb morphogenesis
|
GO:0035137 |
2 |
0.026
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.026
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.026
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.026
|
|
|
|
positive regulation of dna metabolic process
|
GO:0051054 |
73 |
0.026
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.025
|
|
|
|
basement membrane organization
|
GO:0071711 |
3 |
0.025
|
|
|
|
organelle fission
|
GO:0048285 |
149 |
0.025
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
28 |
0.025
|
|
|
|
intraspecies interaction between organisms
|
GO:0051703 |
14 |
0.025
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
56 |
0.025
|
|
|
|
signal release
|
GO:0023061 |
70 |
0.025
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
73 |
0.025
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.025
|
|
|
|
regulation of notch signaling pathway
|
GO:0008593 |
18 |
0.025
|
|
|
|
positive regulation of mononuclear cell proliferation
|
GO:0032946 |
47 |
0.025
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.024
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.024
|
|
|
|
head development
|
GO:0060322 |
108 |
0.024
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
166 |
0.024
|
|
|
|
salivary gland morphogenesis
|
GO:0007435 |
4 |
0.024
|
|
|
|
spermatid differentiation
|
GO:0048515 |
4 |
0.024
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.024
|
|
|
|
tube morphogenesis
|
GO:0035239 |
95 |
0.024
|
|
|
|
nuclear export
|
GO:0051168 |
69 |
0.024
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.024
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
86 |
0.024
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
104 |
0.023
|
|
|
|
endoderm development
|
GO:0007492 |
33 |
0.023
|
|
|
|
regulation of autophagy
|
GO:0010506 |
52 |
0.023
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.023
|
|
|
|
regulation of lipase activity
|
GO:0060191 |
37 |
0.023
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.023
|
|
|
|
positive regulation of stress activated mapk cascade
|
GO:0032874 |
60 |
0.023
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.023
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
185 |
0.023
|
|
|
|
pharynx development
|
GO:0060465 |
1 |
0.022
|
|
|
|
lymphocyte activation
|
GO:0046649 |
133 |
0.022
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
42 |
0.022
|
|
|
|
regulation of epithelial cell migration
|
GO:0010632 |
93 |
0.022
|
|
|
|
angiogenesis
|
GO:0001525 |
147 |
0.022
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
166 |
0.022
|
|
|
|
late endosome to vacuole transport
|
GO:0045324 |
2 |
0.022
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.022
|
|
|
|
autophagic cell death
|
GO:0048102 |
3 |
0.022
|
|
|
|
cardiac ventricle formation
|
GO:0003211 |
2 |
0.021
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
69 |
0.021
|
|
|
|
endoderm formation
|
GO:0001706 |
33 |
0.021
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
60 |
0.021
|
|
|
|
exosomal secretion
|
GO:1990182 |
15 |
0.021
|
|
|
|
mitochondrial membrane organization
|
GO:0007006 |
40 |
0.021
|
|
|
|
positive regulation of alpha beta t cell activation
|
GO:0046635 |
10 |
0.021
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
48 |
0.021
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.021
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.021
|
|
|
|
regulation of ossification
|
GO:0030278 |
58 |
0.021
|
|
|
|
brain development
|
GO:0007420 |
97 |
0.021
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.021
|
|
|
|
regulation of histone modification
|
GO:0031056 |
47 |
0.020
|
|
|
|
hormone metabolic process
|
GO:0042445 |
61 |
0.020
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
40 |
0.020
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.020
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.020
|
|
|
|
dephosphorylation
|
GO:0016311 |
209 |
0.019
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.019
|
|
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.019
|
|
|
|
chromosome segregation
|
GO:0007059 |
114 |
0.019
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.019
|
|
|
|
reproductive process
|
GO:0022414 |
106 |
0.019
|
|
|
|
meiotic chromosome segregation
|
GO:0045132 |
4 |
0.019
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.019
|
|
|
|
mesoderm development
|
GO:0007498 |
14 |
0.019
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
130 |
0.019
|
|
|
|
neutrophil degranulation
|
GO:0043312 |
3 |
0.019
|
|
|
|
glial cell migration
|
GO:0008347 |
4 |
0.019
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
38 |
0.019
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.019
|
|
|
|
reproductive structure development
|
GO:0048608 |
55 |
0.019
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
176 |
0.019
|
|
|
|
regulation of chromatin organization
|
GO:1902275 |
56 |
0.019
|
|
|
|
cytokine secretion
|
GO:0050663 |
64 |
0.019
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
4 |
0.018
|
|
|
|
pyridine containing compound metabolic process
|
GO:0072524 |
18 |
0.018
|
|
|
|
pyridine containing compound biosynthetic process
|
GO:0072525 |
3 |
0.018
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.018
|
|
|
|
epiboly involved in gastrulation with mouth forming second
|
GO:0055113 |
1 |
0.018
|
|
|
|
monocarboxylic acid biosynthetic process
|
GO:0072330 |
67 |
0.018
|
|
|
|
cellular response to estrogen stimulus
|
GO:0071391 |
16 |
0.018
|
|
|
|
regulation of nervous system development
|
GO:0051960 |
88 |
0.018
|
|
|
|
visual behavior
|
GO:0007632 |
2 |
0.018
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
35 |
0.018
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
17 |
0.018
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.018
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.017
|
|
|
|
insulin secretion
|
GO:0030073 |
39 |
0.017
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
94 |
0.017
|
|
|
|
immune system development
|
GO:0002520 |
195 |
0.017
|
|
|
|
regulation of cell activation
|
GO:0050865 |
125 |
0.017
|
|
|
|
regulation of cell division
|
GO:0051302 |
116 |
0.017
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
48 |
0.017
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.017
|
|
|
|
vesicle transport along microtubule
|
GO:0047496 |
4 |
0.017
|
|
|
|
negative regulation of actin filament bundle assembly
|
GO:0032232 |
9 |
0.017
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.017
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
3 |
0.017
|
|
|
|
osteoclast development
|
GO:0036035 |
2 |
0.016
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
68 |
0.016
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
128 |
0.016
|
|
|
|
cellular response to radiation
|
GO:0071478 |
65 |
0.016
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
205 |
0.016
|
|
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.016
|
|
|
|
cognition
|
GO:0050890 |
43 |
0.016
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.016
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.016
|
|
|
|
positive regulation of response to external stimulus
|
GO:0032103 |
88 |
0.016
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.016
|
|
|
|
neuron development
|
GO:0048666 |
113 |
0.016
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
3 |
0.016
|
|
|
|
regulation of dna repair
|
GO:0006282 |
47 |
0.016
|
|
|
|
visual learning
|
GO:0008542 |
1 |
0.016
|
|
|
|
regulation of peptidyl lysine acetylation
|
GO:2000756 |
22 |
0.016
|
|
|
|
stem cell proliferation
|
GO:0072089 |
25 |
0.016
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
46 |
0.016
|
|
|
|
mitotic dna integrity checkpoint
|
GO:0044774 |
30 |
0.016
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.015
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.015
|
|
|
|
mast cell mediated immunity
|
GO:0002448 |
5 |
0.015
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.015
|
|
|
|
response to metal ion
|
GO:0010038 |
84 |
0.015
|
|
|
|
thyroid hormone metabolic process
|
GO:0042403 |
4 |
0.015
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.015
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
1 |
0.015
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
94 |
0.015
|
|
|
|
regulation of developmental growth
|
GO:0048638 |
30 |
0.015
|
|
|
|
pyruvate metabolic process
|
GO:0006090 |
26 |
0.015
|
|
|
|
phototransduction visible light
|
GO:0007603 |
2 |
0.015
|
|
|
|
nucleobase catabolic process
|
GO:0046113 |
4 |
0.015
|
|
|
|
urea metabolic process
|
GO:0019627 |
3 |
0.015
|
|
|
|
leukocyte cell cell adhesion
|
GO:0007159 |
37 |
0.014
|
|
|
|
notch signaling pathway
|
GO:0007219 |
31 |
0.014
|
|
|
|
stem cell division
|
GO:0017145 |
2 |
0.014
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.014
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
65 |
0.014
|
|
|
|
protein tetramerization
|
GO:0051262 |
47 |
0.014
|
|
|
|
regulation of small gtpase mediated signal transduction
|
GO:0051056 |
156 |
0.014
|
|
|
|
response to fatty acid
|
GO:0070542 |
13 |
0.014
|
|
|
|
cell projection morphogenesis
|
GO:0048858 |
129 |
0.014
|
|
|
|
response to inorganic substance
|
GO:0010035 |
127 |
0.014
|
|
|
|
response to salt stress
|
GO:0009651 |
3 |
0.014
|
|
|
|
modification dependent protein catabolic process
|
GO:0019941 |
209 |
0.014
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.014
|
|
|
|
positive regulation of interleukin 1 production
|
GO:0032732 |
14 |
0.014
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
3 |
0.014
|
|
|
|
axon development
|
GO:0061564 |
34 |
0.014
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
64 |
0.014
|
|
|
|
pituitary gland development
|
GO:0021983 |
2 |
0.014
|
|
|
|
cytolysis
|
GO:0019835 |
8 |
0.013
|
|
|
|
muscle cell migration
|
GO:0014812 |
19 |
0.013
|
|
|
|
protein kinase b signaling
|
GO:0043491 |
69 |
0.013
|
|
|
|
regulated secretory pathway
|
GO:0045055 |
20 |
0.013
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.013
|
|
|
|
detection of light stimulus involved in sensory perception
|
GO:0050962 |
9 |
0.013
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.013
|
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
64 |
0.013
|
|
|
|
stress activated protein kinase signaling cascade
|
GO:0031098 |
94 |
0.013
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
103 |
0.013
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
190 |
0.013
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.013
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.013
|
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
95 |
0.013
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
2 |
0.012
|
|
|
|
negative regulation of alpha beta t cell activation
|
GO:0046636 |
3 |
0.012
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.012
|
|
|
|
response to estrogen
|
GO:0043627 |
47 |
0.012
|
|
|
|
cell cell signaling
|
GO:0007267 |
155 |
0.012
|
|
|
|
leukocyte mediated cytotoxicity
|
GO:0001909 |
27 |
0.012
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
204 |
0.012
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
76 |
0.012
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
4 |
0.012
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.012
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.012
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.012
|
|
|
|
organic acid transport
|
GO:0015849 |
65 |
0.012
|
|
|
|
response to drug
|
GO:0042493 |
81 |
0.012
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.012
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
12 |
0.012
|
|
|
|
cell cell junction organization
|
GO:0045216 |
69 |
0.012
|
|
|
|
photoreceptor cell differentiation
|
GO:0046530 |
2 |
0.012
|
|
|
|
inositol phosphate mediated signaling
|
GO:0048016 |
16 |
0.012
|
|
|
|
negative regulation of secretion by cell
|
GO:1903531 |
52 |
0.011
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
244 |
0.011
|
|
|
|
cellular response to light stimulus
|
GO:0071482 |
34 |
0.011
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.011
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
179 |
0.011
|
|
|
|
dna replication
|
GO:0006260 |
116 |
0.011
|
|
|
|
dna biosynthetic process
|
GO:0071897 |
40 |
0.011
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
24 |
0.011
|
|
|
|
receptor metabolic process
|
GO:0043112 |
81 |
0.011
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
72 |
0.011
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.011
|
|
|
|
modulation of transcription in other organism involved in symbiotic interaction
|
GO:0052312 |
20 |
0.011
|
|
|
|
negative regulation of interleukin 8 secretion
|
GO:2000483 |
2 |
0.011
|
|
|
|
forebrain development
|
GO:0030900 |
26 |
0.011
|
|
|
|
positive regulation of extracellular vesicular exosome assembly
|
GO:1903553 |
4 |
0.011
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
81 |
0.011
|
|
|
|
regulation of cytokine secretion
|
GO:0050707 |
57 |
0.011
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
117 |
0.011
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.011
|
|
|
|
negative regulation of cell cycle g1 s phase transition
|
GO:1902807 |
29 |
0.011
|
|
|
|
positive regulation of cytoplasmic transport
|
GO:1903651 |
82 |
0.011
|
|
|
|
positive regulation of binding
|
GO:0051099 |
45 |
0.011
|
|
|
|
leukocyte activation
|
GO:0045321 |
164 |
0.010
|
|
|
|
social behavior
|
GO:0035176 |
14 |
0.010
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
64 |
0.010
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
144 |
0.010
|
|
|
|
cellular senescence
|
GO:0090398 |
34 |
0.010
|
|
|
|
neutrophil homeostasis
|
GO:0001780 |
3 |
0.010
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
80 |
0.010
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
71 |
0.010
|
|
|
|
nucleobase containing compound transport
|
GO:0015931 |
51 |
0.010
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.010
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
45 |
0.010
|
|